GENE ONLINE|News &
Opinion
Blog

Chronic Kidney Disease
GSK’s Jesduvroq Wins FDA Approval for First Oral Drug for Anemia In Chronic Kidney Disease
2023-02-02
Highlights of ASN Kidney Week 2022
2022-11-02
AstraZeneca’s Treatment for Chronic Kidney Disease Wins Yet Another Approval
2022-09-05
Amgen Out-Licenses Two Therapies to Fosun Pharma to Expand Presence in China
2022-06-28
EU Greenlight for Bayer’s Kidney Disease Drug, Kicking off Market Rivalry Against Established SGLT-2 Inhibitors 
2022-03-01
Australia’s CSL Makes $11.7 Billion Bid for Swiss Drugmaker Vifor
2021-12-15
FDA Okays Bayer’s Kidney Disease Drug, Kicking Off Market Rivalry Against Established SGLT-2 Inhibitors
2021-07-12
FDA Greenlights AstraZeneca’s Blockbuster Drug for Chronic Kidney Disease
2021-05-02
China’s NMPA Greenlights LOKELMA Label Update for Haemodialysis, Hyperkalaemia Patients
2020-11-27
Multifaceted Farxiga Shows Benefit in Chronic Kidney Disease
2020-07-30
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top